Lilly To Acquire Orna Therapeutics for $2.4 Bn 
By

By
Eli Lilly and Company has agreed to acquire Orna Therapeutics, a bio/pharmaceutical company dedicated to engineering immune cells in vivo, for $2.4 billion.  Orna is advancing a class of therapeutics using engineered circular RNA paired…

Sanofi Appoints New CEO 
By

By
Sanofi has appointed Belén Garijo, currently Chair and CEO of Merck KGaA, as CEO, effective April 29, 2026. She will succeed Paul Hudson, the company’s current CEO, who will remain CEO until February 17, 2026. Olivier Charmeil, currently Executive Vice President, General…

Supplier News: Fujifilm Biotechnologies & Rentschler Biopharma 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Biotechnologies & Rentschler Biopharma.   Biologics Manufacturing * Fujifilm Biotechnologies Opens $546-M UK Biomanufacturing Expansion Appointments * Rentschler Biopharma Appoints New COO  Biologics Manufacturing  Fujifilm Biotechnologies Opens…

Global Briefs: Lilly, Takeda, Moderna & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company, Takeda, Moderna, Alkermes, and CSL. Highlights below.   For the latest news roundup on small and Emerging Pharma…

Biotech Briefs: Novo Holdings & Madrigal Pharmaceuticals 
By

By
The latest from small and Emerging Pharma companies featuring the European Life Sciences Coalition, Madrigal Pharmaceuticals, and Ribocure.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * European Life…

Lilly Investing $3.5 Bn in New US Injectable Mfg Facility 
By

By
Eli Lilly and Company has announced an investment of $3.5 billion in a new manufacturing facility in Pennsylvania. The expansion is part of the company’s multi-year $50-billion investments in US capital expansion…

FDA Launches Precheck Pilot Program for US Pharma Mfg 
By

By
The US Food and Drug Administration (FDA) has announced that it is accepting requests to participate in the FDA PreCheck pilot program, a new program the agency says is designed to…

Indian Gov’t To Invest $1.1 Bn To Support Biologics & Biosimilars Hub 
By

By
The Indian government has announced the launch of Biopharma Shakti, a national initiative with an investment of $1.1 billion over five years, aimed at strengthening India’s end-to-end ecosystem for biologics and biosimilars.  …

Supplier News: Piramal Pharma, Nanologica, Cellares & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma Solutions, Nanologia/Ardena, Cellares/Stanford and Mabtech/Sai Life Sciences.   Chemicals/Chemical API Manufacturing * Nanologica Acquires API Mfg Facility from Ardena Formulation Development/Drug Product Manufacturing * Piramal Pharma Solutions Introduces…

Global Briefs: AstraZeneca, Roche, Takeda & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring AstraZeneca, Roche, Takeda, and SK bioscience. Highlights below.   For the latest news roundup on small and Emerging Pharma companies, see Biotech Briefs.  Partnering…